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Abstract
Adequate medication management is a focus of effective care that is often overlooked in
caring for adults with comorbid psychiatric and physical conditions, especially in patients who
are treated by multiple care providers and have a variety of health issues at the same time. The
purpose of this project was to develop evidence-based policies and practice guidelines to reduce
polypharmacy in elderly patients in a rural outpatient psychiatric clinic. Bandura’s self-efficacy
theory was used to inform the project for its value in assessing motivation, capacity for selfregulation, and perceptions of individual ability. An interdisciplinary team of stakeholders
explored best practices for electronic health records (EHR) in a rural mental health facility,
created policy and practice guidelines, and developed implementation and evaluation plans to
guide the initiative as it moves forward. The team included physicians, psychiatrists,
psychologists, nurse practitioners, nursing support staff, social workers, and substance abuse
counselors. The team explored approaches for implementing EHR–based medication
management based on research in the current literature and goals/objectives of each department.
Team members identified major issues and proposed guideline changes based on evidence in
their own fields. The team then collaborated to develop policies and practice guidelines in a
series of meetings designed to build consensus for supporting a unified set of products to be
accepted by all departments. The resulting policies and practice guidelines are accompanied by
plans for implementation and evaluation that provide the institution with a comprehensive
solution to polypharmacy in elderly patients. This project may improve overall quality of care by
reducing medication and preventing health complications related to polypharmacy.
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Section 1: Nature of the Project
Introduction
Polypharmacy in populations of adults age 65 or older is a significant issue, especially in
populations receiving care in mental health facilities. In this evidence-based project, I assessed
the problem of polypharmacy from a variety of perspectives, provided a definition for
polypharmacy for this specific population, and proposed a method that can be implemented to
create greater accountability in addressing the needs of an aging population through the use of
electronic health records (EHRs). When implemented, this project will have the potential of
changing the way in which healthcare professionals address the needs of their patients in rural
health clinics, including assessing their medication needs and seeking information that can
prevent polypharmacy in this vulnerable population through the use of improved technologies.
Background
Medical advancements in the 20th century and improvements in the quality of life across
populations have led to improvements in longevity in the United States. This has led to the aging
of the American society, which brings about increasing healthcare needs for older adults (CDC,
2013). The percentage of the population over the age of 65 will increase to more than 20% by
2030, and this population currently consumes more than 66% of the country’s outlay for
healthcare (CDC, 2013). Estimates suggest that unless there is another major shift by 2050,
Americans over the age of 65 will exceed 89 million (CDC, 2013).
These figures demonstrate the breadth of the challenge that emerges when attempting to
meet the healthcare needs of the population over the age of 65. Over the course of their lifespans,
people develop many different conditions impacting health, and chronic disease is more common
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in this population than in any other. Conditions prevalent in this population include heart disease,
cancer, diabetes, and mental illness, all of which are frequently treated pharmacologically (CDC,
2013). Therefore, the threat of polypharmacy, or the overprescribing of multiple medications, is
especially problematic for this vulnerable population.
Inappropriate drug use in elderly populations occurs in about 14% of communitydwelling patients and rises to 40% among nursing home residents (Trivalle et al., 2010).
Subsequently, the problem of polypharmacy is becoming increasingly common in older adults
and poses considerable challenges for practitioners, including nurse practitioners working in
psychiatric outpatient clinics in rural settings. Developing methods and strategies to improve
patient outcomes and to reduce adverse events is becoming a necessary component of care for
elderly patients.
Problem Statement
The problem focused on in this project is the way in which nurses and other professionals
address the issue of polypharmacy in elderly patients in rural outpatient psychiatric clinics.
Polypharmacy is the use of multiple medications to treat a single illness or a syndrome in one
individual patient. It is a common practice among the elderly, both for physical health issues and
mental health issues. One of the confounding issues in the rural psychiatric clinic where I
practice is that most elderly psychiatric patients have more than one chronic illness; they often
have several. Many researchers have shown that these elderly patients are receiving several
prescriptions from different physicians that may increase their risk for adverse drug reactions.
Adequate management of patient medication regimens can be a difficult component of
care, primarily because many practitioners rely on reports from patients about their medications,
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both prescribed and over-the-counter, in order to determine the need for additional medications
or if adverse interactions might occur. This results in the problem of polypharmacy, which Viktil
et al., (2007) described as “the concurrent use of multiple drugs … the use of more drugs than
are clinically indicated or too many inappropriate drugs” (p. 187). Hoffman et al., (2011)
maintained that this can sometimes reflect an imprecise view of the overall problem in relation to
psychiatric patients, so they more clearly defined polypharmacy for this population as the use of
two or more medications in the same patient to treat the same condition, or the use of two or
more of the same chemical class of medications used to treat the same psychiatric ailment.
For geriatric psychiatric patients who often have multiple comorbid psychiatric and
physical conditions, polypharmacy can result from the use of multiple psychiatric drugs, multiple
prescribers, and/or the use of drugs that result in adverse drug reactions because of the lack of
continuity in communications regarding overlapping medication regimens (Hoffman et al.,
2011). Slabaugh et al., (2010) also maintained that polypharmacy can complicate the treatment
process for elderly patients who have multifactorial health states and require medications for
psychiatric conditions. Another problem for elderly populations is that medication regimens may
become less effective over time, resulting in the perceived need for additional medications,
especially in the treatment of psychiatric conditions (Bilyeu et al., 2011).
Purpose Statement
The purpose of this DNP project was to create a quality improvement program with the
aim of reducing polypharmacy in elderly patients in a rural outpatient psychiatric clinic. This
quality improvement program focused on three specific areas designed to reduce polypharmacy:
1. Identifying all medications, prescribed and over-the-counter, used by each patient;
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2. Increasing patient understanding of the purpose and side effects of each medication; and
3. Improving communications between practitioners to reduce the opportunities for
polypharmacy.
The focus of this project was the incorporation of new policies and systems in a
multidisciplinary team approach to improving patient care.
Goals and Outcomes
The goal of this project was to create a quality improvement program with the aim of
reducing polypharmacy in elderly patients in a rural outpatient psychiatric clinic. The goal of
developing the project to reduce polypharmacy required the ability to assess current perspectives
on changing the present system and the level of commitment that individuals have to improving
patient outcomes.
For the purpose of assessing perspectives on the planned change, the definition of
polypharmacy reflected the concurrent use of multiple drugs for the treatment of the same
clinically indicated illness and the presence of inappropriate drug use, or the use of multiple drugs
in a manner that is ineffective, excessive, or can result in adverse events (Viktil et al., 2007).
Creating a multidisciplinary approach to reducing polypharmacy required an assessment of current
systems, the creation of recommendations from the multidisciplinary team for change, and an
assessment of the views of practitioners about their commitment to reducing the problem of
polypharmacy.
The most significant measurable outcomes for this project at the time it was proposed
were to demonstrate reduction in polypharmacy from current levels to no incidences after
implementation of the multidisciplinary team-initiated EHR project. Because no level of

5
polypharmacy would be acceptable and because of the severity of adverse reactions for the elderly
population studied, the use of EHRs as a change in protocol was believed to ensure reduction to
zero events after implementation. The EHR system identifies when three or more medications are
being prescribed for a single patient to treat the same condition, so different providers have the
option to go back in and assess their prescribing decisions to prevent polypharmacy. Once the
EHR alerts the prescribing professional of the presence of polypharmacy resulting from their
prescribing choice, they can then initiate discourse with the other professionals and refrain from
their current prescribing plan as a way to prevent polypharmacy. Subsequently, the use of EHRs in
combination with the multidisciplinary method was viewed as an approach to use; the technology
and the protocols for addressing polypharmacy could reduce the level of polypharmacy in the rural
facility to zero.
Frameworks for the Project
The quality improvement program was defined by a multidisciplinary model that
enhanced communications and improved identification of risk factors for polypharmacy. In
correlation with this approach, though, a nursing theory was applied to the focus of educational
support services and improved patient participation. Creating a system that supported more
effective communication had to start with an effective understanding of treatment modalities and a
self-awareness for the patients themselves. This included a focus on self-efficacy theory. Selfefficacy theory can be used to assess a person’s motivation, capacity for self-regulation, and
perceptions regarding individual ability to meet particular end goals, including effective
medication management (Bandura, 1997). Self-efficacy theory was applied to health promotion
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activities for patients that are based on a patient’s choices and behaviors and the adaptations
necessary for change.
Nature of the Project
This evidence-based project focused on the implementation of an EHR-based approach
that ensured the documentation and sharing of information about patient care across
multidisciplinary teams and ensured improved information sharing for the treatment of elderly
populations in a rural psychiatric outpatient facility. The rationale for this approach was the
belief that this type of method could be effective in reducing adverse events that occur as a result
of polypharmacy through closer tracking of patient drug use (Viktil et al., 2007). The creation of
this program and the strategies for implementation focused on the specific use for elderly
patients who are at greater risk of polypharmacy and the perceived benefits of and resistance to
this kind of approach in reducing the problem.
Significance of the Project
Elderly populations seeking treatment in rural psychiatric outpatient clinics may have a
long history of psychiatric disorders and demonstrate problems that range from effective
adherence to medication regimens to the need for periodic and/or systematic changes in
medication that can impact the level of control over the psychiatric disorder (Greenawalt, 2009;
Hoffman et al., 2011; Hogan & Kwan, 2006). For example, an elderly patient may have
experienced years of well-controlled bipolar disorder and may find that he or she is suddenly
experiencing symptoms. This patient may be treated by one or more practitioners, who may
prescribe a range of medications to treat the symptoms. Changes in physiological processing of
medication and changing levels of response to medication may result in a variety of different
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views on the best treatment modalities for the patient. In addition, the presence of comorbid
health conditions and medications can result in polypharmacy that has a negative impact on the
patient’s psychiatric and physical condition.
Most practitioners reflect on the patient’s history, including prescribing history, as a part
of their evaluation of the need for new medications (Hutchinson, 2008). At the same time, a
focus on patient self-reports of medication and the present use levels for medication does not
always reflect a full and complete assessment of the medication regimen. Subsequently,
practitioners need to determine more effective strategies for gaining insight into patient
medication use, medication regimens prescribed, and the potential for adverse events each time a
patient presents in the rural psychiatric outpatient clinic.
The significance of the project related directly to the increase in the number of elderly
patients seeking services, the increasing need for effective medication management, and the
noted number of adverse events that occur as a result of medication mismanagement. There were
approximately 40 million people living in the United States over the age of 65 in 2010, which
comprises about 13% of the population. That number will jump to over 72 million in 2030,
increasing to about 20% of the population (Federal Interagency Forum on Aging-Related
Statistics, 2012).
There are distinct physiological and psychological changes that occur with age. Elderly
adults experience changes that impact how medications are processed, and this can change
expected outcomes of medications. Specifically, bioavailability can be impacted by age, and this
is reflective of changes that correspond with aging, including weight gain, changes in excess fat
deposition, and changes in GI processing, increased levels of stress, and decreased levels of
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physical activity (Porter & Kaplan, 2012). As people age, their metabolism of medications can
slow, and this corresponds both with a general slowing of their metabolism and the impacts of
physical condition, all of which require adjustments to drug interventions or therapies that are
being used for elderly patients.
Patients aged 65 and older often experience suboptimal pharmacotherapy, primarily
because of changes in drug metabolism, target organ sensitivity, problematic drug interactions,
and even drug toxicity (Trivalle et al., 2010). Commonly, these changes result in longer periods
of drug activity, which can have a greater or lesser drug effect, and an increased level of
potential toxicity resulting from metabolic changes (Trivalle et al., 2010). Cefalu (2006)
maintained that while this predisposition to adverse reactions occurs in populations over the age
of 65, the most problematic outcomes of these reactions occur in patients over the age of 85, who
can take an average of five to eight drugs each day. Cefalu stated that a number of reports have
shown that the risk of adverse drug events in elderly patients rises with comorbidity; increasing
numbers of medications; inappropriate medications; the use of antipsychotics, anticoagulants,
diuretics, and antiepileptics; and the use of multiple prescribers and pharmacies by patients and
caregivers.
The use of a patient profile and pharmacology questionnaire should occur at each visit,
including an identification of any alternative treatments or supplements that could interfere with
the function of other drugs. Sharing this information through the use of electronic health records
was identified as the program approach best suited to reduce polypharmacy and improve patient
outcomes.
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Implications for Social Change
Disease rates have decreased over the last quarter century, at the same time that life
expectancy rates of the elderly have increased for both men and women (FIFARS, 2012).
Longevity has led to the increasing need for medical services, including services for both
psychiatric and physiological health concerns. Many people over the age of have prescriptive
and nonprescriptive medications used to treat pain, inflammation, and problematic symptoms
related to their conditions. Men and women over 65 are more likely than any other single
population to take multiple medications at one time. While some of these medications may be
prescribed, it is not uncommon for patients to use a combination of prescribed medication and
over-the-counter drugs and supplements that can result in problematic interactions.
Inappropriate drug use in elderly populations occurs in about 14% of communitydwelling patients rising to 40% in nursing home residents (Trivalle et al., 2010). Subsequently,
the problem of polypharmacy is becoming increasingly common in older adults and poses
considerable challenges for practitioners, including nurse practitioners working in psychiatric
outpatient clinics in rural settings. Developing methods and strategies to improve patient
outcomes and reduce adverse events is becoming a necessary component of care for elderly
patients.
Definitions of Terms
Adverse drug events (or Adverse medication events): Adverse drug events, or adverse
medication events, occur when a patient’s medication is not managed effectively and the patient
experiences physiological or psychological responses that are undesirable, including decline in
health or mental status resulting from the level, combination or type of medications used.

10
Electronic health records: A technology-based documentation and charting system that
provides practitioners and clinicians with access to patient information at a wide range including
remote locations to ensure the accuracy of patient health information that informs medical
treatment.
Inappropriate drug use: Inappropriate drug use is drug use that is either ineffective,
excessive, or results in adverse medication events (Trivalle et al., 2010).
Polypharmacy: Polypharmacy can be described as “the concurrent use of multiple
drugs,[or]…the use of more drugs than are clinically indicated or too many inappropriate drugs”
(Viktil et al., 2007, p. 187).
Quality improvement program: The quality improvement program used for this DNP
project will focus on closer scrutiny and documentation of patient prescribing regimens and
medication intake, scrutiny of each patient’s regimen, and more effective communication within
a multidisciplinary team. This quality improvement program will be supported by evidencebased practices identified in the current literature.
Rural outpatient psychiatric clinic: The rural outpatient psychiatric clinic used for the
purpose of this study is a facility that provides services for patients with psychiatric disorders
that can be managed through medication and support services while residing at home. In this
case, the psychiatric outpatient clinic is one located in a rural area and generally provides
services for a patient population living within 40 miles of the clinic.
Assumptions and Limitations
The assumption at the onset of this study was that the problem of polypharmacy existed
in the general population and would be found to some degree in participants in a rural psychiatric
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outpatient facility. This study was also based on the assumption that other mitigating factors,
including decreased educational level of rural patients and decreased communication between
practitioners using electronic medical records, played a role in the level of polypharmacy in this
facility. The study was limited by the focus on a single rural facility and the willingness of
practitioners on the multidisciplinary team to support transitions from the protocols currently in
place.
Summary
In this project, I focused on the level of service being provided to patients in a rural
outpatient psychiatric clinic, especially in relation to the use of medication regimens. One of the
struggles that practitioners in this kind of setting had was that they often were not fully aware of
the level of medication that a patient was taking and may have prescribed more than one
medication for the same condition or may have experienced difficulties in assessing the
medications a patient is taking. A strategy that was beneficial to support patients in this setting in
reducing adverse events, especially in elderly populations, was to support a level of patient
education and patient/practitioner communication that was maintained by a multidisciplinary
team. In this project, I assessed the level of polypharmacy for elderly patients in this clinical
setting and considered the implications of creating improved services, focusing on the use of
EHR in determining methods for reducing adverse events.
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Section 2: Review of Literature and Theoretical and Conceptual Framework
Introduction
This project was designed to assess the impact of a quality improvement program
designed to address the problem of polypharmacy in elderly patients in a rural outpatient
psychiatric clinic. This problem was identified in a variety of studies about polypharmacy,
adverse events, issues in elderly medical care, and in the presence of comorbid conditions in
elderly populations. Current studies on the changing nature of the elderly population, increasing
issues with medication management, and the need for better methods of communication were all
a part of the review of literature provided (Cefalu, 2006; Greenawalt, 2009; Hoffman et al.,
2011; Hogan & Kwan, 2006; Hutchinson, 2008; Porter & Kaplan, 2012; Trivalle et al., 2010;
Viktil et al., 2007).
The review of literature includes an overview of the literature search strategy and an
identification of major models and theories used to support the change initiative. The literature
was used to identify the scope of the problem in the specific context of care in the rural
outpatient mental health facility. The relevant literature selected demonstrated the scope of the
problem and the strategies that were used in the past, including the use of medical records, to
support positive outcomes in reducing polypharmacy.
Literature Search Strategy
An initial Google Scholar search was conducted to determine if any recent online
resources could be located in full-text and to determine if other search terms should be used.
Some of the search terms considered for this project included polypharmacy, elderly, adverse
events, mental health, electronic medical records, and electronic health records. Other terms,
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including hospital and nursing, were included to distinguish medical studies from studies in
other fields (e.g., social services) in which assessments of adverse events might occur. The
search that produced the most potential sources in Google Scholar was one that used the terms
polypharmacy and elderly and also limited sources to nursing journals. This search produced 711
results that included studies on polypharmacy in the elderly, adverse events in the elderly, and
views of strategies used to prevent adverse events. Of the first two pages of results, though, only
four sources had any reference to a specific focus on comparisons of different strategies that
were used with patients.
A search of the CINHAL, Healthsource, and Medline databases produced a much
smaller body of overall literature. One of the key aspects of the search was to limit to full-text
sources in order to ensure that the resources could be viewed and used. After completing a search
limited by data (2006-2014), full-text status, and peer reviewed sources, a search of the terms
polypharmacy and elderly and also limited sources to nursing journals resulted in 41 full-text
studies, only 17 of which pertained to the topic being investigated. The sources selected included
those that addressed some of these separate parameters as a foundation for a study on the link
between adverse events and polypharmacy, especially in patients with mental illness.
The body of evidence that was produced from a search of terms related to the impact of
polypharmacy in elderly patients in the rural mental health setting presented a range of
information that included surveyed responses, a focus group, and a retrospective review of
patient data. One of the key issues in exploring this topic was that many of the studies that were
produced to support hospital redesign measures were carried out in the early 2000s, and much of
the current literature focused on the end products of specific design approaches, including
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methods of improving patient safety and the use of medical health records. The lack of current
literature that indicated the benefits of this kind of change in rural mental health facilities
produced the gap in literature that suggested the need for the benefits of the proposed approach.
Scope of the Problem
The existing literature related the scope of the problem of polypharmacy in elderly
populations to the increasing number of elderly in this country. In 2009, approximately 12.9% of
the U.S. population was over the age of 65, amounting to approximately 39.6 million people
(Administration on Aging, 2014). This number is expected to almost double by 2030, reaching
72.1 million people (American Agency on Aging, 2014).
In addition to comprising a large segment of the population, people over the age of 65
comprise a significant portion of the population using pharmaceuticals. Elderly populations use
more than 50% of all prescribed medications and 40% of all over-the-counter medications in this
country (Pretorius et al., 2013). More than 90% of all elderly patients not institutionalized are
taking at least one form of prescription medication on a regular basis (Pretorius et al., 2013). For
those actively participating in regular healthcare-related maintenance, elderly people over the age
of 65 are likely to have six to eight medications they are taking at the same time to address a
range of comorbid health conditions (Pretorius et al., 2013). As the number of medications being
prescribed or used increases in this population, the risk of adverse events also increases. Fulton
and Allen (2005) identified the risks of the use of two medications at 15% for elderly
populations, while that risk level increases to 58% with five medications and to 82% with seven
medications. These researchers further asserted that as the number of medications increases, the
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risk for adverse events also increases, and this defined the impetus for relating literature about
this problem.
Risks for Psychiatric Populations: Background and Context
A variety of literature has indicated that polypharmacy is particularly problematic in
geriatric patients and in psychiatric populations (Langan & Shajahan, 2010; Tiihonen et al.,
2012; Zink, Englisch, & Meyer-Lindberg, 2010). While the current literature reflected the nature
of this problem in regards to psychiatric patients in clinical settings, the assumption that these
individuals were uninvolved in their medication management was a general misnomer
recognized by researchers, including Mizokami et al., (2012) and Munger (2010). Literature has
indicated that communications and effective medication management is a cooperative element
requiring compliance, support, and regular assessments in order to reduce the chances of
problematic medication mismanagement (Tiihonen et al., 2011). Existing literature has
maintained the importance of the use of technology and the use of patient support mechanisms to
reduce the chances of polypharmacy that results in adverse events (Langan & Shajahan, 2010).
Suokas et al., (2013) conducted a large nationwide study to determine the prevalence and
potential predictors of long-term polypharmacy specific to patients receiving treatment for
schizophrenia. This project specifically focused on the impacts of antipsychotic polypharmacy in
patients and reflected on those who had experienced at least one hospitalization during the study
period for schizophrenia (Suokas et al., 2013). The researchers conducted a cohort study defined
by the presence of hospitalization for schizophrenia between 2000 and 2007 in order to
determine if antipsychotic polypharmacy had occurred. Because of the precarious nature of
treatment modalities for patients with schizophrenia, these researchers identified the problem of
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polypharmacy simply as patients being prescribed two or more overlapping prescriptions for
different antipsychotics in a 60-day period (Suokas et al., 2013). They found that patients with
schizophrenia and antipsychotic polypharmacy were at an unacceptable level, with more than
46% of patients experiencing this problem. In addition, the researchers posited that there were
implications that this kind of prescribing mismanagement in the case of schizophrenic patients
will possibly require hospitalization.
Literature specific to the issue of polypharmacy in elderly patients with psychiatric
disorders referred to the connections amongst changing psychiatric medications, the changes in
patient needs, and the comorbid conditions that exist for elderly patients, all of which can
increase the risk of polypharmacy. This specific project provided a foundation for understanding
the overall problem and could subsequently be applied to the scrutiny of the process at a rural
outpatient psychiatric clinic.
Patient Health Worldwide
Research about polypharmacy and its potential impacts has been conducted in the
international community for decades. Sato and Akazawa (2013), for example, maintained that it
is common in Japan for elderly populations to have multiple comorbidities and to be medicated
by multiple practitioners, increasing the chances that individuals will experience adverse drug
reactions. These researchers further maintained that the risk of adverse drug reactions increases
when patients are taking five or more medications and when they are being treated for both
psychiatric and physiological health issues. In Japan, this is especially true of a growing
population of elderly patients who are hypertensive and being treated for psychiatric conditions,
amongst others (Sato & Akazawa, 2013). One of the notable elements in this Japanese study is
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that researchers found there were times when multiple medications were being used to treat the
same condition, which both was unnecessary and increased the risk of adverse events.
Other studies in international populations also underscored the problem of polypharmacy
in elderly populations and the increased risk of problematic health impacts. For example, Jyrkk
et al., (2009) assessed populations of elderly patients in Finland and found that adverse
physiological implications could also be assessed as a result of polypharmacy. The researchers
found that it was not uncommon for elderly patients receiving multiple medications, some for the
same conditions, to experience greater levels of physical instability. Subsequently, elderly
patients in their Finnish cohort study demonstrated a higher degree of physiological instability
leading to falls and individual injury resulting from polypharmacy (described as the use of six to
nine drugs) or excessive polypharmacy (the use of 10 or more drugs; Jyrkk et al., 2009). The
researchers found that excessive polypharmacy was a significant underlying cause of increased
mortality rates amongst elderly populations and indicated the importance of addressing the issue
of multiple prescribing physicians’ communications and the need for improved medication
management in order to decrease the use of multiple medications for the same conditions (Jyrkk
et al., 2009).
In an Egyptian study of elderly populations, researchers found that polypharmacy and the
inappropriate use of certain types of medication was more common in elderly patients than in
any other population (Hamza et al., 2012). The researchers studied populations of people over
the age of 60 and found that polypharmacy occurred in 56% of the subjects studied, and this
included the use of prescribed medications from multiple practitioners. Inappropriate use of
medications was especially high in this population, with about 41% receiving inappropriate or
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poorly managed medications, including contraindicated medication combinations (Hamza et al.,
2012). Because the use of antidepressants and antipsychotic medications in elderly populations is
on the rise, the significant association between the use of multiple practitioners and
polypharmacy was an element identified in the study as increasing the risk of adverse events
(Hamza et al., 2012).
In a study of subjects in Sweden, Haider et al., (2009) maintained that a range of factors
can impact the effectiveness of medication management and can serve to foster problematic
adverse drug events in patients with medical and psychiatric comorbidities. Researchers in this
study evaluated the impacts of low levels of educational attainment on the ability of elderly
patients to assess and self-manage their medication regimen. These researchers maintained that a
lower educational level was associated with a higher degree of polypharmacy and the potential
for adverse events occurring from inappropriate drug use (Haider et al., 2009). Lower levels of
educational attainment increased the risk of individuals taking three or more psychotropic drugs,
and these individuals had a high level of adverse events resulting from polypharmacy, especially
when comorbidity between psychiatric and physiological issues emerged (Haider et al., 2009).
In a study of Nigerian patients, prescribing patterns for patients over the age of 65 years
suggested a very high level of inappropriate medication use, primarily because of the presence of
multiple practitioners and lack of effective medication self-management by patients (Fadare et
al., 2013). After evaluating medical records for 220 patients, the researchers found that the
patients were prescribed an average of almost four medications per person, including
medications for hypertension as well as medications for psychological conditions. Polypharmacy
that could result in adverse events (specifically, potentially inappropriate medication prescribing)

19
occurred in almost 26% of the cases. Similarly, Chirn-Bin et al., (2011) maintained that elderly
patients in a Taiwan study experienced inappropriate prescribing with significant frequency,
resulting in adverse events occurring as often as 24% of the time. One of the problems that
emerged, as noted by Chirn-Bin et al., is that medication regimens are often not assessed until
patients experience an adverse event. For elderly patients who may already be experiencing
physiological fragility, waiting until an adverse event occurs to address polypharmacy is a risky
proposition.
Salih et al., (2013) explored polypharmacy in outpatient clinics in Saudi Arabia and
found that of 766 patients, 89% were taking five or more medications prescribed by physicians
each day. The most frequently treated conditions included hypertension, diabetes mellitus, and
dyslipidemia, but a range of other conditions also existed, including depression, cardiovascular
disease, and pain management medications. The presence of polypharmacy and the risk of
adverse events are often discussed in contrast to appropriate medication management and the
focus for elderly patients on medication compliance (Salih et al., 2013). As a result, the World
Health Organization has sought to determine ways of reducing polypharmacy in geriatric
patients, recognizing that many elderly experience polypharmacy as they are treated for a range
of conditions, including psychiatric diseases, by different practitioners (as cited in Shah, Gajjar,
& Desai, 2012). The World Health Organization has identified an imperative to improve the
quality of care for geriatric patients and to promote the rational use of medications through
increased communication and patient medication management systems.
The general literature provided an understanding of the issue of polypharmacy as a whole
and the potential risks involved. The literature showed studies from all over the world that
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indicated that even in areas where technology is commonly applied, the use of multiple
prescribing practitioners and the lack of adequate patient information resulted in poor outcomes
for patients. This information also furthered an understanding of the specific issues for elderly
patients, many of whom experienced comorbid conditions that resulted in a wide range of
medications and potential adverse medication reactions.
The Application of Quality Improvement Strategies: Concepts, Models, and Theories
The quality improvement program was defined by a multidisciplinary model that
enhanced communications and improved identification of risk factors for polypharmacy. In
correlation with this approach, though, a nursing theory was also applied to the focus of
educational support services and improved patient participation. Creating a system that supported
more effective communication had to start with effective understanding of treatment modalities
and self-awareness in the patients themselves. This included a focus on self-efficacy theory. Selfefficacy theory could be used to assess a person’s motivation, capacity for self-regulation, and
perceptions regarding individual ability to meet particular end goals, including effective
medication management (Bandura, 1997). Self-efficacy theory could be applied to health
promotion activities for patients who are based on a patient’s choices and behaviors and the
adaptations necessary for change.
Self-efficacy theory is based on the “beliefs in one’s capabilities to organize and execute
the courses of action required producing given attainments” (Bandura, 1997, p. 3). In using selfefficacy theory as a foundation for promoting health, it is important to recognize that selfefficacy is behavior-specific and reflects beliefs and perceptions regarding one’s own skills and
abilities and their application. Self-efficacy generally describes the perceptions and feelings a
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person has towards goal achievement and his or her own participation in transformative
behaviors. Self-efficacy relates to both internal and external cues and individuals and social
messages that can impact a person’s motivation, self-confidence, and perceptions regarding
capacity to reach health promotion goals, including reduction of polypharmacy and the patient’s
effective self-management of medication regimens.
The connection between self-efficacy theory and any program developed to determine
methods to reduce polypharmacy should be education-based and should focus on methods of
supporting improved interactions between practitioners in the clinical setting and patients
requiring support. The connection between methods for improving outcomes and specific
approaches utilized by patients to take part in their care suggested a beneficial line to explore as
a part of programming to reduce polypharmacy.
Measuring Polypharmacy: Framework
There are two strategies for measuring polypharmacy and specifically providing data for
the evaluation of measures to reduce polypharmacy through the use of electronic health records
(EHRs): the use of a patient questionnaire before and after implementation of the change
initiative or the comparison of health record data and comparisons before and after
implementation of EHR use. Studies that reflect the use of both of these measures are identifying
the issue of polypharmacy in this particular population and creating a body of comparative data.
Rambhade et al., (2012), for example, created a questionnaire that was specifically designed to
assess polypharmacy by reviewing demographic information, prescribing physicians, date of
prescriptions, purpose of the use of the prescription in medical treatment, a complete list of
current medical conditions, and any signs and symptoms related to the use of medications. The
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information in the study by Rambhade et al., (2012) was collected using the questionnaire
categories as the survey instrument and semi-structured patient interviews. Before the onset of
the interview, patients agreeing to participation were asked to bring a list of all their medications
and prescription dates to the interview, as well as any over-the-counter medications they were
taking not prescribed by a physician. This type of interview provided a large body of current data
and the same type of interviews can be conducted following the implementation of an electronic
health record system in order to evaluate the implications for reducing polypharmacy.
Another option for measuring reductions in polypharmacy would be to assess the level of
medication use and the specific patient diagnoses in a population in a health facility utilizing
traditional recording methods, and comparisons with the electronic medical record data that can
be collected after implementation. Freund, Meiman and Kraus (2013) demonstrated the use of
medical records to characterize the level of medication use based on demographic characteristics,
including age, and the evaluation of polypharmacy in relation to specific patient conditions
identified through the use of this electronic data. This approach to evaluating data allowed for
the application of a retrospective inquiry into patient medication use, categories of medication
prescribed, and prescribing conditions, all of which was derived in correlation with patient
demographics and comorbidities. When assessing this kind of data, Freund, Meiman and Kraus
(2013) found that patients in older demographic groups had a much higher level of
polypharmacy and comorbidity than younger groups, placing them at higher risk of adverse
events.

23
Section 3: Methodology
Introduction
In this quality improvement project, I used a multidisciplinary team to determine
protocols for the use of EHRs with the aim of reducing polypharmacy for geriatric patients
seeking treatment in a rural outpatient psychiatric clinic. The purpose of this DNP project was to
create a quality improvement program with the aim of reducing polypharmacy in elderly patients
in a rural outpatient psychiatric clinic.
Overall Approach/Rationale
The overall approach to developing a multidisciplinary team approach was to address the
problem of polypharmacy based on the need to determine the best route for change and to
determine a collaborative set of policies that ensured adequate communication across
departments. The following activities were central to the progression of the quality improvement
initiative from an initial idea to an applicable set of steps that was implemented:
1.

I acted as the leader of a multidisciplinary team created to develop a quality improvement

program based on EHR technology to reduce polypharmacy. The team included a range of
different institutional stakeholders, with individuals responsible for prescribing medication for
this population. As a result, I was responsible for selecting and integrating members of a
multidisciplinary team in the development of policies and protocols to reduce polypharmacy.
2.

I led the multidisciplinary team in exploring studies on the use of EHRs in reducing

medication polypharmacy and adverse events caused by medication errors (Croll, 2010; Jha et
al., 2010).
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3.

I led the project term to develop policy and practice guidelines.

4.

I validated the content of policies and practice guidelines by sharing the information with

scholars in the field. This provided a foundation for assessing the mechanisms for change in
alignment with their views of evidence-based approaches.
5.

I led the project team to develop an implementation plan and an evaluation plan (See

Appendix C and D).
6.

This approach provided a cost-effective system for creating a change initiative because it

focused on my work in leading a team and creating the plan.
Assembling the Team
I approached departmental leaders at a rural psychiatric facility and outlined the project
parameters. The departmental leaders were then asked to provide recommendations within their
departments for participants in the project team. After collecting a document of potential
candidates for participation in the team, members of each of the multidisciplinary stakeholder
groups were approached and asked to participate. This process continued until at least one
member of each stakeholder group was identified for participation in the team.
The multidisciplinary team was comprised of physicians, psychiatrists, psychologists,
licensed clinical social workers, substance abuse counselors, nurse practitioners, and nursing
support staff who provided direct services to geriatric psychiatric patients in a rural outpatient
clinic. The team included one representative from each discipline among those who were present
and discussed any suggestions, challenges, and concerns with the group about the
implementation of a quality improvement strategy. This team also distinguished roles for the
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implementation of the quality improvement program and determined lines of communication to
support improvements in medication management across disciplines. The team met once a week
for 6 weeks.
During the first weekly meeting, the team was asked to come together and identify
themselves and discuss any specific skills they have that they bring to the table for resolving the
major problem of polypharmacy for geriatric populations. This was done as a part of the strategy
of opening dialogues and sharing information that could improve departmental communications.
The team then assessed the existing policies and practice guidelines of the organization in order
to identify any deficiencies in relation to medication management and documentation systems.
The team members identified issues and provided a rationale for any changes that were proposed
and subsequently implemented. This meeting set the stage for group decision-making at the next
meetings. This meeting also determined the roles of participants and set goals to be completed
before the next meeting. These goals included seeking evidence-based practice research in
support of any proposed changes.
At the second and third weekly meeting, the team members discussed research, pursued
additional research, and identified the specific policy changes proposed as extensions of the
development process. The group discussed how effective the change initiative was in meeting the
goals set by the group in regards to reductions in polypharmacy and improved medication
management. I presented information derived from research and assembled a report for the group
on the goals met by the proposed change.
At the fourth meeting of the team, the group provided a structure for the policy changes
and discussed how the changes would be applied in specific policy outcomes. The team also
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related methods for integrating policy changes, including educational and informational sessions
to be used with staff, and the implications of not implementing the changes as identified in the
new policy guidelines (See Appendix A).
The final meeting provided a wrap-up of the process, which included a review of the
policy, a review of the literature pertaining to the change, and a review of instructional/
informational content that was shared across departments. This end meeting was the culmination
of the first five team sessions and concluded with the production of a clear guideline and
presentation process for integrating the change initiative in the organization (See Appendix B).
Description of the Products
The primary products that were created through the project and team involvement in the
DNP project included a new set of policies related to the use of electronic medical records to be
used as the foundation for integrating EHRs into different aspects of patient care (See
Appendices A and B). The primary products of the DNP project included the creation of specific
policies and practice guidelines used in the clinical setting (Appendices A and B). The members
of the multidisciplinary team were responsible for the creation of the primary products, and I
provided a narrative review of these products. Validation procedures were based on an
evaluation of outcomes and patient data both before and after implementation. The comparative
data was evaluated on a departmental level in order to assess areas of change and areas in which
the change initiatives were most effective (Croll, 2010; Jha et al., 2010). This corresponded with
existing literature about the benefits of electronic record keeping in relation to patient process
and also related to the findings of each department about the overall level of adverse events as
reflections of the success or failure of policy changes.
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The secondary products include an implementation plan (Appendix C) used to assess the
levels of polypharmacy and the nature of adverse events prior to the integration at each level of
the organization and an evaluation plan (Appendix D) used to determine variations in the
outcomes for patients before and after implementation of the policies and practice guidelines.
Project team members worked collaboratively to create the policy and practice guideline changes
and to assess levels of need for each department prior to implementation. Implementation
practices were discussed through collaboration on departmental levels. Each team member
demonstrated a commitment to foster in others the same commitment to apply the initiative in
the workplace. The validation procedures for the secondary products were based on an
evaluation of existing literature and best practice approaches, including literature related to the
use of technology and methods for developing policies across departments.
Time and Resource Constraints
This project required participation of members in the multidisciplinary team during a 6week period in the fall and winter of 2015. This constraint was related both to the parameters of
the team process and the need to complete the project in a limited span of time. Because project
team participants were asked to be part of the team process on a volunteer basis, there was not a
significant budget allocated to the use of staffing resources in the hospital setting. Subsequently,
the project budget was limited to expenses I incurred.
Developing Policy and Practice Guidelines
The general policy change was integrated through the multidisciplinary team, which
applied the change initiative that was designed to improve the quality of care by reducing
polypharmacy. The policy specifically addressed the roles of different players at each tier of the
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organization and has promoted the use of improved documentation systems through EHRs and a
structured approach to care that ensured that patient prescribing information could be
communicated to each practitioner who provided the patient with care (Croll, 2010; De Wet,
2011; Harrington, 2011; Jha et al., 2010). The policies developed were assessed in relation to the
evidence-based practices identified in the existing literature to determine the set of practices that
would be used at the clinic.
The leadership approach that I took in leading the team to successful policy development
and implementation focused on a transformational leadership approach, which can be described
as a style that raises leadership to the next level. Transformational leadership involves inspiring
followers to commit to a shared vision and goals…challenging them to be innovative problem
solvers, and developing [their] capacity via coaching, mentoring, and provision of both challenge
and support (Bass & Riggio, 2006, p. 4).
Transformational leadership can also be described as “the process whereby a person
engages with others and creates a connection that raises the level of motivation and morality in
both the leader and the follower” (Northouse, 2012, p. 186). Because of the significance of this
issue and the need for a more effective approach to improving patient care, this leadership style
was used to help foster a sense of commitment to the change initiative during the study process.
Data and Participants
The setting for this study was a rural outpatient psychiatric clinic. This setting was
selected in order to evaluate the factors that impact the services provided for patients in this kind
of setting and the potential implications for services orientation using a multidisciplinary team
approach. This type of clinic was also selected because of limitations in its communication
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modalities and its approaches to medication management in order to support the potential of a
quality improvement program to improve services.
The specific clinic provided support for people with a range of psychiatric disorders,
including geriatric patients with schizophrenia, bipolar disorder, substance use disorders, and
depression. In addition, this clinic frequently works with patients who have recently been
released after short-stay hospital visits for psychiatric or physiological health conditions;
referrals to the clinic were provided to improve patient outcomes after hospitalization.
Implementation Plan Products
I acted as the leader of the multidisciplinary team that developed a plan to be
implemented in each department that provided directives for methods of communication and the
use of EHRs in the rural facility. The multidisciplinary team determined which practitioners were
responsible and had access to EHRs. The team also determined which practitioners providing
support services would do follow-ups, which professionals provided educational support for
patients, and which providers were in charge of communicating with other practitioners the
information necessary to ensure appropriate medication management.
The policy plan and informational presentation were distributed to a number of specialists
in the area of polypharmacy and policy development, an expert from School of Pharmacy, Yorba
Linda University, and my preceptor, who is also an expert in the area of polypharmacy, working
with geriatric patients, and who is an adjunct professor at USC and UCLA. These individuals
were selected because of their work and their specific focus on the issue of polypharmacy in
mental illness and methods to prevent polypharmacy in the elderly.
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Evaluation Plan Products
I was responsible for assessing the outcomes of the project and my team determined what
data were used and how they influenced assessments of the change initiative over time. The team
also determined if information collected would be compared to national data collected from the
current literature about the level of polypharmacy in this country, the level of polypharmacy in
psychiatric patient populations, and the number of overall adverse events that occur as a measure
of the success or failure of the change initiative.
Summary
The objectives and outcomes of this program were based on a DNP candidate-led
multidisciplinary team that was formed to address the issue of polypharmacy in a rural mental
health facility. The team members focused on methods to improve patient outcomes based on the
use of electronic health records to be used to reduce polypharmacy in rural outpatient psychiatric
clinics. This was based on the practice changes determined by the team during weekly meetings
over a 6-week period.
This plan for use of a DNP candidate-led team in creating a change initiative was
recognized as a method of contributing to evidence-based practice by providing documentation
of support for developing quality improvement methods that reduced polypharmacy. This project
focused on a multidisciplinary approach to supporting improvements in the use of EHRs,
attention to patient evaluation, and improved understanding of medication compliance. The
application of the project in this area was viewed as a way of helping to defend the need for
differentiated services in the outpatient psychiatric clinic linked to the quality improvement
measure. This program was in response to an identified need in the clinical setting, in this case
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the need to reduce polypharmacy for elderly patients, and the perceived benefits of the use of
improved technologies.
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Section 4: Findings, Discussion, and Implications
Introduction
For geriatric patients who frequently experience multiple comorbid physical and
psychiatric conditions, the issue of polypharmacy is especially problematic. The use of multiple
drugs prescribed by multiple prescribers, sometimes for the same condition, can result in adverse
drug reactions (Hoffman et al., 2011). Polypharmacy can cause significant adverse events and
can hinder effective treatment for elderly patients who have multifactorial health states. In the
rural psychiatric facility, the focus of this project is the implementation of a strategic approach to
reducing polypharmacy by improving communication and documentation methods of a range of
providers (Slabaugh et al., 2010). The purpose of this DNP project was to create a quality
improvement program with the aim of reducing polypharmacy in elderly patients in a rural
outpatient psychiatric clinic. The expected outcomes of this study were to identify medications
for each patient, increase patient knowledge, improve communications between practitioners,
and reduce polypharmacy through the use of EHRs. Reducing polypharmacy requires a
commitment on the part of practitioners to support improved patient outcomes through the
implementation of a quality improvement change initiative.
The primary products that were developed as a part of this process included a set of
policy and practice guidelines (Appendices A and B). The secondary products developed
included an implementation plan (Appendix C) and an evaluation plan (Appendix D). The
implementation plan was developed with the goal of assessing the levels of polypharmacy and
adverse events before a change initiative. The evaluation plan was developed to determine
variations in the outcomes through the process of implementation of policies and practice
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guidelines. The policy and practice guidelines were created with input from a multidisciplinary
team to clearly identify expectations and changes. The overall results of the project included the
creation of a multidisciplinary team, the development of a set of policies and protocols for the
use of EHRs in the clinical setting, and the successful implementation and evaluation of the
change initiative.
Discussion of Project Products
The project process required specific steps, the first of which was the creation of a
multidisciplinary team. This team was responsible for the development of the project products,
including the implementation and evaluation plans as well as the policy and practice guidelines
that will dictate how the change initiative is maintained in the clinical setting over time. These
products provide the framework and support for the change initiative and demonstrate the
connection between what were the practices in the facility at the time and the gaps in information
that had to be addressed to reduce polypharmacy. The implementation plan was created with the
aim of evaluating the levels of polypharmacy and the impacts of adverse events in order to define
the scope of the problem.
The implementation plan identified the specific areas of the organization and the level of
involvement without actually being derived from an implementation process. These areas
included the organizational level and departmental level. One of the most compelling statements
made by participants in the multidisciplinary team was that there needed to be protocols and
systems that were maintained at the organizational level and implemented at the departmental
level, and this was demonstrated in the differentiation between the two in the implementation
plan outline in Appendix C.
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The implementation plan included organizational evaluations of the key access points for
EHRs in order to determine how effective a change initiative using EHRs could be, the existing
organizational directives for the prescribing systems already in place, and the overall problem of
polypharmacy for the organization as a whole. In conjunction with these points, the
implementation plan also related the need for the integration of technology-based reporting
systems and the underlying connection between these systems and funding mechanisms for the
mental health facility. The reflections for the organization as a whole are provided in Appendix
E.
From a departmental standpoint, the implementation plan took on a much more concrete
focus and identified the level of responsibility as well as the departmental expectations for the
use of EHRs, and it specifically noted the occupations in which participation in the change
initiative would be mandated. This included identifying every person in each department who
would have access to EHRs and all of the people involved in prescribing at each level of the
organization. In order to create an impetus for acceptance of the change initiative, the focus on
levels of polypharmacy for each was a necessary component of the implementation plan. Finally,
the implementation plan at the departmental level also included the identification of methods
through which technology could be expanded and individuals trained to ensure adequate use.
An example of potential results from the departmental assessment is included in
Appendix F. This specifically focused on the key components of the implementation plan and
potential outcomes for the Geriatric Psychology department of the mental health facility, because
of the prevalence of this problem for the specific population being assessed and the role of the
department in addressing their service needs. The information provided in this implementation
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plan addressed the specific needs of the department in terms of overall prescribers, access point
needs, and the problems that relate specifically to how polypharmacy is assessed, including intake information and its impacts.
The evaluation plan provided in Appendix D outlined the variations in the outcomes
through the process of implementing policies and practice guidelines. The organizational rubric
set out the parameters for assessing planning, initiation, strategic implementation, policy
assessment, and successful outcomes in relation to the different aspects of the problem:
communication, polypharmacy, and adverse events. One of the notable elements regarding
communications in the interdisciplinary team was that adverse events were not reported as
concretely as they should have been. One nurse practitioner maintained that not all adverse
events that were likely impacted by polypharmacy were described that way in the evaluation or
treatment process, and so were not always indicated in data collected about the level of impact
on a department.
The project focused on the planning and development process, and so outcomes of the
implementation and evaluation were not a part of this project. Members of the multidisciplinary
team reflected on how they perceived the implementation and evaluation plan processes to
evolve, and this information is provided in Appendices E, F, and G.
The policy guidelines outlined in Appendix A were the foundation for the change
initiative and were clearly identified by the multidisciplinary team as the foundation for the
changes that occurred. These represent the end product, and modifications were not made to
these policies after they were finalized. The policies included the use of EHRs for patient
documentation, the use of EHRs across departments, the use of technology to support accuracy
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in record keeping, the identification of privacy approaches that are in alignment with HIPAA to
diminish breaches of privacy from multiple access points, and the use of educational systems in
the mental health facility to improve overall integration of technology. Multidisciplinary team
members worked collaboratively to create the policy and practice guideline changes and to
assess levels of need for each department prior to implementation. Implementation practices
occurred through collaboration on departmental levels. Each team member demonstrated a
commitment to the process of change and fostered commitment in others to apply the change
initiative to the workplace process.
The outcomes of this project reflected the views of team members about the connection
between communication modalities and the approaches to maintaining accurate records for
geriatric patients, specifically with the aim of reducing polypharmacy. For geriatric patients who
have multiple comorbid conditions, polypharmacy is becoming increasingly common when
communication between practitioners is inadequate (Hoffman et al., 2011). Members of the
multidisciplinary team maintained that even though their facility was relatively small,
communications did not occur on a regular basis to support the accuracy of patient care plans in
reflecting the prescribing practices for each patient. This corresponds with the findings of
researchers including Slabaugh et al., (2010), who argued that polypharmacy for elderly patients
is exacerbated by the fact that there are multiple states of health that may be treated by a range of
practitioners, resulting in medication regimens that overlap. For example, Bilyeau et al., (2011)
maintained that conditions like depression may be treated by multiple practitioners, including a
psychiatrist and a general practitioner, seeing the same symptoms in a patient.
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One of the challenging aspects of creating the plan and identifying approaches to change
within the multidisciplinary team was settling on a definition of the problem of polypharmacy.
The team settled on creating a definition and reflecting the need for intervention based on the
belief that polypharmacy can be seen as the concurrent use of multiple drugs for the treatment of
the same clinically indicated illness as well as the presence of inappropriate drug use or the use
of multiple drugs in a manner that is ineffective, excessive, or can result in adverse events (Viktil
et al., 2007).
The most significant measurable outcomes sought in this project were the demonstration
of a reduction in polypharmacy from current levels to no incidences after implementation of the
multidisciplinary team-initiated EHR project. Though this was clearly an aim of the process, the
details identified in Appendices E, F, and G reflected projected views of what could occur when
implemented. This was based on the assertion that no level of polypharmacy would be
acceptable in the clinical setting and that EHRs should trigger a report when multiple prescribers
enter data about patient process into the system. One of the key tracking elements of this
operation involves the constant use of updated material and ready access to the EHR system.
Members of the multidisciplinary team questioned the methods for implementation that could
occur through the application of the project and the impact for project outcomes. Participation
and compliance with EHR use is imperative in any facility where the project is implemented
because of the mechanisms involved in ensuring that polypharmacy does not occur. The EHR
system identifies when three or more medications are being prescribed for an individual patient
for a single condition or when overlapping prescriptions have been produced by multiple
providers. When the EHR notifies the prescribing professional of the presence of polypharmacy
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during the chart update process, the practitioner has a number of opportunities to contact the
other professional or assess the orders that exist for the patient in order to make necessary
corrections to avoid polypharmacy. Even in light of these protocol changes and the policy
development, members of the multidisciplinary team maintained that errors may still occur even
after implementation of the EHR system.
In the evaluation of outcomes related to the DNP project, I took on a number of roles,
including the leader of the multidisciplinary team and the liaison between each department and
the team itself. The team focused on the creation of the policy plan and also provided narrative
information about any problem, its potential solutions, and major areas of concern in relation to
the use of EHR systems and the training protocols needed for successful implementation. I was
also responsible for assessing the outcomes of the project and for integrating narrative data and
specific resources to determine if practitioners believed polypharmacy might continue once the
plan is implemented.
Implications
Policy
The change initiative developed in this DNP project has a number of implications for
policy, practice, research, and social change. The general policy change was integrated through
the multidisciplinary team to apply the change initiative designed to improve the quality of care
for the geriatric patients being served in the mental health facility. As a result, the policy change
was in alignment with the goal and it reflected an evidence-based approach (Croll, 2010; De
Wet, 2011; Harrington, 2011; Jha et al., 2010). Subsequently, the DNP project resulted in policy
changes that were implemented departmentally and across the organization.
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Practice
The policy changes also determined specific practice changes, including changes in the
way communications occur across departments and in the approaches used to document patient
process. The use of EHRs was the defining element in this practice change, and it led to
significant alterations in communication systems and approaches to care. Increasingly, the team
approach for creating the policies reflected a greater need for such team approaches in providing
patient care. Because of the significance of this issue and the need for a more effective approach
to improving patient care, this focus of this process resulted in improved function in the facility
as a whole.
Research
In this research, I identified provided a foundation for policy changes and demonstrated
the application of best-practice approaches related to research evidence. Current studies on the
changing nature of the elderly population, increasing issues with medication management, and
the need for better methods of communication are all a part of the review of literature provided
(Cefalu, 2006; Greenawalt, 2009; Hoffman et al., 2011; Hogan & Kwan, 2006; Hutchinson,
2008; Porter & Kaplan, 2012; Trivalle et al., 2010; Viktil et al., 2007). Research has indicated
that polypharmacy was a significant problem that had to be addressed through the policy changes
(Langan & Shajahan, 2010; Tiihonen et al., 2012; Zink et al., 2010). Existing research has
supported the value of the use of technology and the use of patient support mechanisms to reduce
the chances of polypharmacy that result in adverse events (Langan & Shajahan, 2010). These
elements were clearly identified in the change initiative for the facility.
Social Change
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The change initiative and policy decision-making also reflected the importance of
improving outcomes as a social change strategy. The overall problem of polypharmacy has a
significant impact on populations as a whole, and this project sets the tone for increasing use of
technology in rural settings to improve patient outcomes (Trivalle et al., 2010). Correspondingly,
the importance of creating mechanisms through which communications can advance to improve
patient outcomes was also clearly demonstrated in this project. Both of these elements support
social change because they improve outcomes for patients while addressing the need for
improvements in a variety of different settings.
Dissemination of the Project
The implications for both research and social change require the dissemination of this
project to other professionals who can benefit from the information presented. As a result, this
DNP project will be presented in informal nursing settings in mental health facilities and at a
conference on mental health nursing.
Strength and Limitations of the Project
This study provided an accurate reflection of the range of different ways in which EHRs
can be used to ensure medication use is in alignment with patient needs, and the use of data from
a facility and a multidisciplinary team are both strengths of this project. One of the weaknesses is
that this project did limit the focus to the application in a single rural facility and so the outcomes
cannot fully be understood if applied in other settings.
Analysis of Self
As a DNP candidate, I recognized the importance of accurate and adequate
communication in the care of patients and also sought methods to ensure that this could occur in
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rural settings where practitioners may be spread out over different facilities. My focus was to
ensure that communication could occur and that medication management was as accurate as
possible through the use of new technologies. I sought this information and used a
multidisciplinary team approach to developing protocols for its use in the rural mental health
facility. The policy development process required a leader for the multidisciplinary team and I
became this leader, employing a variety of leadership techniques and fostering beneficial
communication in the group through a transformational leadership model. Transformational
leadership involves inspiring followers to commit to a shared vision and goals, “…challenging
them to be innovative problem solvers, and developing [their] capacity via coaching, mentoring,
and provision of both challenge and support” (Bass & Riggio, 2006, p. 4). This was my focus
during the process, and I used a range of strategies during the team process to realize applicable
change. I gained a significant amount of insight into the development of policy through the
discourse about policy process and also recognized the variety of stakeholders who can be
involved and the different stakeholder interests that are reflected when discussions about policy
process occur.
As a practitioner, scholar and project manager, I found that the two elements are
intertwined when exploring major policy changes in the clinical setting. The stakeholders
involved in the process of change frequently require a broad range of information supporting a
change initiative, and solid leadership requires a rationale for change in order to challenge
resistance. The use of the team approach had significant benefits in addressing stakeholder
concerns and in creating an effective method for communicating both the need for change and
the approaches to best address change in each department.
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The long-term goals for myself as a practitioner, scholar, and project manager include
some of the same elements: to maintain a consistent message, to demonstrate understanding of a
range of perspectives, to strive for greater knowledge, and to enact effective change.
Recognizing that nursing is a dynamic profession requiring continuous change and constant
awareness of stakeholder interests should be a foundational element in driving nursing research.
After this DNP project was completed, I recognized my need to constantly assess the best
approaches in nursing care and to determine strategic approaches through the application of
effective research.
Summary
Research clearly indicates that polypharmacy is particularly problematic in geriatric
patients and in psychiatric populations as a whole (Langan & Shajahan, 2010; Tiihonen et al.,
2012; Zink, Englisch, & Meyer-Lindberg, 2010). There is increasing evidence that effective
communication and effective medication management go hand-in-hand, and this project
provided additional support for this assertion. Communication and management systems that are
technology-based, including the use of electronic health records (EHRs) provide a foundation for
communications between varied practitioners in the rural mental health facility and can help to
reduce the level of polypharmacy.
The aim of this DNP project was to create a quality improvement program for reducing
polypharmacy in elderly patients in a rural outpatient psychiatric clinic. The multidisciplinary
team created and supported a policy change and new technologies. This information suggests
the need for continued study of the impacts of EHRs in the clinical setting and continued
research into the best approaches to reducing adverse events from poor medication management.
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Section 5: Scholarly Product
Abstract
Adequate medication management should be a focus of effective care for patients, but can often
be overlooked in caring for adults with comorbid psychiatric and physical conditions. This is
especially true when patients see multiple care providers and when they have a variety of health
issues that are being treated at the same time. The purpose of this DNP project was to create a
quality improvement program with the aim of reducing polypharmacy in elderly patients in a
rural outpatient psychiatric clinic. The theoretical foundations are based on Bandura’s (1997)
self-efficacy theory used to assess a person’s motivation, capacity for self-regulation, and
perceptions regarding individual ability to meet particular end goals. The goals of this project
included creating a multidisciplinary team to explore the best approaches to implementing
electronic health records (EHR) in a rural mental health facility, and creating a policy change and
educational program to implement the new plan developed by the multidisciplinary team. The
multidisciplinary team successfully developed a protocol and educational plan for nursing staff
to apply to the use of EHRs to prevent polypharmacy in the rural psychiatric outpatient setting.
This project led to the creation of protocols for the introduction of an electronic health record
(EHR)-based approach to patient medication management supported by professionals from a
range of fields. This project utilized a multidisciplinary team to explore the best approaches for
implementing an EHR-based approach. The major products for this project included the
multidisciplinary team, the plan for integrating medical records and assessments through EHRs,
and the specific practice guidelines. The problem of polypharmacy is becoming increasingly
common in older adults, and poses a threat to individuals in rural settings. Developing methods
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and strategies to improve patient outcomes and reduce adverse events is becoming a necessary
component of care for elderly patients.
Program Evaluation Report
The preliminary outcomes of the evaluation plan after an initial period of implementation
reflected interesting perspectives on the impacts of each stage of the process. These preliminary
results were reflected in documentation provided in Appendix G. The results included here
integrated both the views of the strategic process and the steps through which changes were
made in relation to improving communication and reducing both polypharmacy and adverse
events. This included relating whether successful outcomes were achieved. Though the aim was
to reduce polypharmacy so that zero adverse events would occur, this goal was not achieved as a
part of the change initiative. Continued participation in the policies and approaches outlined
would determine the continued movement towards this aim over time.
Problem
Adequate management of patient medication regimens can be a difficult component of
care, primarily because many practitioners rely on reports of patients about their medications,
both prescribed and over-the-counter, in order to determine the need for additional medications
or if adverse interactions might occur. This results in the problem of polypharmacy, which Viktil
et al., (2007) described as “the concurrent use of multiple drugs, [or]…the use of more drugs
than are clinically indicated or too many inappropriate drugs” (p. 187). Hoffman et al., (2011)
maintained that this can sometimes reflect an imprecise view of the overall problem in relation to
psychiatric patients, and they more clearly defined polypharmacy for this population as the use
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of two or more medications in the same patient to treat the same condition, or the use of two or
more of the same chemical class of medications used to treat the same psychiatric ailment.
For geriatric psychiatric patients, who often have multiple comorbid psychiatric and
physical conditions, polypharmacy can result from the use of multiple psychiatric drugs, multiple
prescribers, and/or the use of drugs that result in adverse drug reactions because of the lack of
continuity in communications regarding overlapping medication regimens (Hoffman et al.,
(2011). Slabaugh et al., (2010) maintained that polypharmacy can complicate the treatment
process for elderly patients who have multifactorial health states and require medications for
psychiatric conditions. In addition, one of the problems for elderly populations is that medication
regimens may become less effective over time, resulting in the perceived need for additional
medications, especially in the treatment of psychiatric conditions (Bilyeu et al., 2011).
Purpose
The purpose of this DNP project was to develop a quality improvement program with the
aim of reducing polypharmacy in elderly patients in a rural outpatient psychiatric clinic. This
quality improvement program focused on three specific areas designed to reduce polypharmacy:
1-identifying all medications, prescribed and over-the-counter, utilized by each patient; 2increasing patient understanding of the purpose and side effects of each medication; and 3improving communications among practitioners to reduce the opportunities for polypharmacy.
The focus of this program was the incorporation of new policies and systems in a
multidisciplinary team approach to improving patient care.
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Goals and Outcomes
The most significant goal of this project was to introduce a new approach to
systematically addressing the issue of polypharmacy with the aim of reducing the problem in
elderly populations receiving treatment in a rural psychiatric outpatient clinic. The goal of
creating the project to reduce polypharmacy required the ability to assess current perspectives on
changing the present system and the level of commitment that individuals have to improving
patient outcomes through the implementation of the project.
The overall approach to developing a multidisciplinary team method was to address the
problem of polypharmacy based on the need for effective collaborative policies, leading to the
creation of a multidisciplinary team to develop a quality improvement program based on EHR
technology to reduce polypharmacy. The team included a range of different institutional
stakeholders and individuals responsible for prescribing medication for this population.
Significance for Future Practice, Research, and Social Change
Elderly populations seeking treatment in rural psychiatric outpatient clinics may have a
long history of psychiatric disorders and demonstrate problems that range from effective
adherence to medication regimens to the need for periodic and/or systematic changes in
medication that can impact the level of control over the psychiatric disorder (Greenawalt, 2009;
Hoffman et al., 2011; Hogan & Kwan, 2006). For example, an elderly patient may have
experienced years of well-controlled bipolar disorder and may find that he or she is suddenly
experiencing symptoms. This patient may be treated by one or more practitioners, who may
prescribe a range of medications to treat the symptoms. Changes in physiological processing of
medication and changes in the levels of response to a medication may result in a variety of
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different views on the best treatment modalities for the patient. In addition, the presence of
comorbid health conditions and medications can result in polypharmacy that has a negative
impact on the patient’s psychiatric and physical condition.
Most practitioners reflect on the patient’s history, including prescribing history, as a part
of their evaluation of the need for new medications (Hutchinson, 2008). At the same time, a
focus on patient self-reports of medication and the present use levels for medication does not
always reflect a full and complete assessment of the medication regimen. Subsequently,
practitioners need to determine more effective strategies for gaining insight into patient
medication use, medication regimens prescribed, and the potential for adverse events each time a
patient presents in the rural psychiatric outpatient clinic.
The significance of the project related directly to the increase in the number of elderly
patients seeking services, the increasing need for effective medication management, and the
noted number of adverse events that were occurring as a result of medication mismanagement.
The increase in our aging population is ongoing: There were approximately 40 million people
living in the United States over the age of 65 in 2010, which comprised about 13% of the
population (FIFARS, 2012); that number will jump to over 72 million in 2030 to comprise about
20% of the population (FIFARS, 2012).
Literature and Evidence
There are distinct physiological and psychological changes that occur with age. Elderly
adults experience changes that impact how medications are processed, and this can change
expected outcomes of medications. Specifically, bioavailability can be impacted by age, and this
is reflective of changes that correspond with aging, including weight gain, changes in excess fat
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deposition, and changes in GI processing, increased levels of stress, and decreased levels of
physical activity (Porter & Kaplan, 2012). As people age, their metabolism of medications can
slow, which corresponds both with a general slowing of metabolism and the impacts of physical
condition, all of which require adjustments to drug interventions or therapies that are being used
for elderly patients.
Patients aged 65 and older often experience suboptimal pharmacotherapy, primarily
because of changes in drug metabolism, target organ sensitivity, problematic drug interactions,
and even drug toxicity (Trivalle et al., 2010). Commonly, these changes result in longer periods
of drug activity, which can have a greater or lesser drug effect and an increased level of potential
toxicity resulting from metabolic changes (Trivalle et al., 2010).
While the current literature reflected the nature of this problem in regards to psychiatric
patients in clinical settings, the assumption that these individuals were uninvolved in their
medication management was a general misperception that was recognized by researchers,
including Mizokami et al., (2012) and Munger (2010). Literature has indicated that
communications and effective medication management is a cooperative element requiring
compliance, support, and regular assessments in order to reduce the chances of problematic
medication mismanagement (Tiihonen et al., 2011). Existing literature has maintained the
importance of the use of technology and the use of patient support mechanisms to reduce the
chances of polypharmacy that results in adverse events (Langan & Shajahan, 2010).
Suokas et al., (2013) conducted a large nationwide study to determine the prevalence and
potential predictors of long-term polypharmacy specific to patients receiving treatment for
schizophrenia. This project specifically focused on the impacts of antipsychotic polypharmacy in
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patients and reflected on those who had experienced at least one hospitalization for
schizophrenia during the study period (Suokas et al., 2013). The researchers conducted a cohort
study defined by the presence of hospitalization for schizophrenia between 2000 and 2007 in
order to determine if antipsychotic polypharmacy had occurred. Because of the precarious nature
of treatment modalities for patients with schizophrenia, these researchers identified the problem
of polypharmacy simply as patients being prescribed two or more overlapping prescriptions for
different antipsychotics in a 60-day period (Suokas et al., 2013). They found that patients with
schizophrenia and antipsychotic polypharmacy were at an unacceptable level, with more than
46% of patients experiencing this problem. In addition, the researchers posited that there were
implications that this kind of prescribing mismanagement of patients with schizophrenia can lead
to the need for hospitalization.
Cefalu (2006) maintained that while this predisposition to adverse reactions occurs in
populations over the age of 65, the most problematic outcomes of these reactions occur in
patients over the age of 85, who can take an average of 5 to 8 drugs each day. “A number of
reports have shown that the risk of adverse drug events in elderly patients rises with comorbidity;
increasing numbers of medications; inappropriate medications; the use of antipsychotics,
anticoagulants, diuretics, and antiepileptics; and the use of multiple prescribers and pharmacies
by patients and caregivers” (Cefalu, 2006). The use of a patient profile and pharmacology
questionnaire should occur at each visit, including an identification of any alternative treatments
or supplements that could interfere with the function of other drugs. Sharing this information
through the use of electronic health records was identified as the program approach best suited to
reduce polypharmacy and improve patient outcomes.
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Literature specific to the issue of polypharmacy in elderly patients with psychiatric
disorders related to the connection amongst changing psychiatric medications, changing patient
needs, and comorbid conditions that exist for elderly patients, all of which can increas the risk of
polypharmacy. This specific project provided a foundation for understanding the overall problem
and could subsequently be applied to scrutinize the process at a rural outpatient psychiatric
clinic.
Interdisciplinary Teams
Implementing a multidisciplinary approach to reducing polypharmacy required an
assessment of current systems, the creation of recommendations from the multidisciplinary team
for change, and the views of practitioners about their commitment to reducing the problem of
polypharmacy through program implementation. This was completed within the team process as
components of the DNP project. The DNP candidate acted as the leader of the multidisciplinary
team. The project sought to demonstrate reduction in polypharmacy from current levels to no
incidences after implementation of the multidisciplinary team-initiated EHR project planned by
this DNP candidate.
The DNP candidate developed a multidisciplinary team from selected from different
departments and set the goal of creating policies and practice guidelines to reduce polypharmacy.
After selection, the multidisciplinary team explored studies on the use of EHRs in reducing
medication polypharmacy and adverse events caused by medication errors (Croll, 2010; Jha et
al., 2010). This information was then used in the development of policies and practice
guidelines. The project team, led by the DNP candidate, developed policy and practice
guidelines.
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After these policies were developed, the information was shared with scholars in the field
to validate the content of the policies and practice guidelines. This provided a foundation for
assessing the mechanisms for change in alignment with their views of evidence-based
approaches. The project team developed an implementation plan for these polices and methods
for evaluating the outcomes of the policies (See Appendices C and D). The outcomes of the
development process included recognition that the approach provided a cost-effective method of
change that could improve patient outcomes and the quality of care.
This included the strategies for the application of the set of proposed policies in rural
mental health facilities. Because no level of polypharmacy is acceptable and because of the
severity of adverse reactions for the elderly population studied, the use of electronic health
records as a change protocol should aim for reduction to zero events after implementation of the
program planned in this project. The policies and practice guidelines and methods of evaluating
their effectiveness were developed as a part of the multidisciplinary team approach.
1.

The DNP candidate acted as the leader of a multidisciplinary team created to develop a

quality improvement program based on EHR technology to reduce polypharmacy. The team
included a range of different institutional stakeholders, with individuals responsible for
prescribing medication for this population. As a result, the researcher was responsible for
selecting and integrating members of the multidisciplinary team in the development of policies
and protocols to reduce polypharmacy;
2.

The DNP candidate led the multidisciplinary team in exploring studies on the use of

EHRs to reduce medication polypharmacy and adverse events caused by medication errors
(Croll, 2010; Jha et al., 2010).
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3.

The project team, led by the DNP candidate, developed policy and practice guidelines.

4.

The DNP candidate validated the content of policies and practice guidelines by sharing

the information with scholars in the field. This provided a foundation for assessing the
mechanisms for change in alignment with their views of evidence-based approaches.
5.

The project team, led by the DNP candidate, developed an implementation plan and an

evaluation plan (See Appendices C and D)
6.

This approach provided a cost-effective system for creating a change initiative because it

engaged the work of the DNP candidate to lead the team and create the plan.
Discussion and Implications
The outcomes of this project reflected the views of team members about the connection
between communication modalities and the approaches to maintaining accurate records for
geriatric patients, specifically with the aim of reducing polypharmacy. For geriatric patients who
have multiple comorbid conditions, polypharmacy is becoming increasingly common when
communication between practitioners is inadequate (Hoffman et al., 2011). Members of the
multidisciplinary team maintained that even though their facility was relatively small,
communications did not occur on a regular basis to support the accuracy of patient care plans in
reflecting the prescribing practices for each patient. This corresponds with the findings of
researchers including Slabaugh et al., (2010) who argued that polypharmacy for elderly patients
is exacerbated by the fact that there are multiple states of health that may be treated by a range of
practitioners, resulting in medication regimens that overlap. The primary and secondary products
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of this project demonstrate the progression towards this goal through the development of the
team approach and the identification of potential policy and guideline changes.
Primary Products
The primary products created through the team’s involvement in the DNP project
included a new set of policies related to the use of electronic medical records, which created the
foundation for integrating EHRs into different aspects of patient care (Appendices A and B). In
addition to establishing new policies, the primary products of the DNP project included the
creation of practice guidelines used in the clinical setting (Appendices A and B).
Secondary Products
The secondary products included an implementation plan (Appendix C) used to assess the
levels of polypharmacy and the nature of adverse events prior to the integration at each level of
the organization. It also included an evaluation plan (Appendix D) utilized to determine
variations in the outcomes for patients before and after implementation of the policies and
practice guidelines. Project team members worked collaboratively to create the policy and
practice guideline changes and to assess levels of need for each department prior to
implementation. Implementation practices were outlined through collaboration on departmental
levels. Each team member demonstrated a commitment to the process of change and fostered
commitment in others with the view of one day applying the change initiative to the workplace
process.
Summary
Research clearly indicates that polypharmacy is particularly problematic in geriatric
patients and in psychiatric populations as a whole (Langan & Shajahan, 2010; Tiihonen et al.,
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2012; Zink, Englisch, & Meyer-Lindberg, 2010). There is increasing evidence that effective
communication and effective medication management go hand-in-hand, and this research project
provided additional support for this assertion. Communication and management systems that are
technology-based, including the use of electronic health records (EHRs), could provide a
foundation for communications among varied practitioners in the rural mental health facility to
help reduce the level of polypharmacy.
The aim of this project was to create a quality improvement program for reducing
polypharmacy in elderly patients in a rural outpatient psychiatric clinic. The policy changes
produced in this project were designed to ensure reductions in polypharmacy and support
measures for improved quality. These perspectives were seen through narrative data on a
departmental level that supports the continued development of this kind of change protocol. This
information suggests the need for continued study of the impacts of EHRs in the clinical setting
and continued research into the best approaches to reducing adverse events due to poor
medication management.
Dissemination Project
My DNP project was based on the identification of polypharmacy as a significant
problem for health care practitioners and nursing staff in psychiatric hospitals. As the DNP
project coordinator, I sought methods to reduce polypharmacy for this population and pursued
research-based methods to improve patient outcomes. The specific focus of this project was to
bring together a multidisciplinary team to create a set of policies and guidelines to be used for
the implementation of electronic health records as a standard of care to reduce polypharmacy in a
rural mental health facility.
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Polypharmacy in populations of adults age 65 or older is a significant issue, especially in
populations receiving care in mental health facilities. This evidence-based research project
assessed the problem of polypharmacy from a variety of perspectives, provided a definition for
polypharmacy for this specific population, and proposed a method that was preliminarily
implemented to create greater accountability in addressing the needs of an aging population
through the use of electronic health records (EHRs). This project was developed to change the
way in which healthcare professionals address the needs of their patients in rural health clinics,
which includes assessing their medication needs and seeking information, through the use of
improved technologies, that can prevent polypharmacy in this vulnerable population.
Problem
This project is based on the belief that adequate management of patient medication
regimens can be a difficult component of care, but only through doing so can practitioners ensure
the safety of their patients. The problem of polypharmacy is a significant one that impacts
elderly psychiatric populations more than any other single population (Slabaugh et al., 2010).
For geriatric psychiatric patients who often have multiple comorbid psychiatric and physical
conditions, polypharmacy can result from the use of multiple psychiatric drugs, multiple
prescribers, and/or the use of drugs that result in adverse drug reactions because of the lack of
continuity in communications regarding overlapping medication regimens (Hoffman et al.,
2011).
Purpose
The purpose of this DNP project was to develop a quality improvement program with the
aim of reducing polypharmacy in elderly patients in a rural outpatient psychiatric clinic. This
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quality improvement program focused on the creation of policies and guidelines by a
multidisciplinary team to implement the use of EHRs in reducing polypharmacy.
Goals and Outcomes
The overall approach to developing a multidisciplinary team method was to address the
problem of polypharmacy based on the need for effective collaborative policies. This entailed the
creation of a multidisciplinary team to develop a quality improvement program, as well as
policies and guidelines based on EHR technology to reduce polypharmacy. The team included a
range of different institutional stakeholders, including individuals responsible for prescribing
medication for this population.
Significance
The significance of the project related directly to the increase in the number of elderly
patients seeking services, the increasing need for effective medication management, and the
noted number of adverse events that occur as a result of medication mismanagement. There were
approximately 40 million people living in the United States over the age of 65 in 2010, which
comprises about 13 percent of the population (FIFARS, 2012). That number will jump to over 72
million in 2030, increasing to about 20 percent of the population (FIFARS, 2012).
Literature and Evidence
Patients aged 65 and older often experience suboptimal pharmacotherapy, primarily
because of changes in drug metabolism, target organ sensitivity, problematic drug interactions
and even drug toxicity (Trivalle et al., 2010). Commonly, these changes result in longer periods
of drug activity, which can have a greater or lesser drug effect, and an increased level of
potential toxicity resulting from metabolic changes (Trivalle et al., 2010).
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Existing literature maintained the importance of the use of technology and the use of
patient support mechanisms to reduce the chances of polypharmacy that results in adverse events
(Langan, & Shajahan, 2010). Literature specific to the issue of polypharmacy in elderly patients
with psychiatric disorders related to the connection amongst changing psychiatric medications,
changing patient needs, and comorbid conditions that exist for elderly patients, all of which can
increase the risk of polypharmacy. This specific project provided a foundation for understanding
the overall problem and could subsequently be applied to scrutinize the process at a rural
outpatient psychiatric clinic.
The Team
Implementing a multidisciplinary approach to reducing polypharmacy required an
assessment of current systems, the creation of recommendations for change by the
multidisciplinary team, and the views of practitioners about their commitment to reducing the
problem of polypharmacy through program implementation. This was completed within the team
process as components of the DNP project. The project sought to demonstrate reduction in
polypharmacy from current levels to no incidences after implementation of the multidisciplinary
team-initiated EHR project planned by this DNP candidate.
Discussion and Implications
The outcomes of this project reflected the views of team members about the connection
between communication modalities and the approaches to maintaining accurate records for
geriatric patients, specifically with the aim of reducing polypharmacy. For geriatric patients who
have multiple comorbid conditions, polypharmacy is becoming increasingly common when
communication between practitioners is inadequate (Hoffman et al., 2011).
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Primary Products
The primary products that were created through the project and team involvement in the
DNP project included a new set of policies related to the use of electronic medical records to be
used as the foundation for integrating EHRs into different aspects of patient care (Appendices A
and B). The primary products of the DNP project included the creation of specific policies and
practice guidelines used in the clinical setting (Appendix A and B).
Secondary Products
The secondary products included an implementation plan (Appendix C) used to assess the
levels of polypharmacy and the nature of adverse events prior to the integration at each level of
the organization and an evaluation plan (Appendix D) utilized to determine variations in the
outcomes for patients before and after implementation of the policies and practice guidelines.
Project team members worked collaboratively to create the policy and practice guideline changes
and to assess levels of need for each department prior to implementation. Implementation
practices were outlined through collaboration on departmental levels. Each team member
demonstrated a commitment to the process of change and fostered commitment in others with the
view of one day applying the change initiative to the workplace process.
Summary
Research clearly indicates that polypharmacy is particularly problematic in geriatric
patients and in psychiatric populations as a whole (Langan & Shajahan, 2010; Tiihonen et al.,
2012). There is increasing evidence that effective communication and effective medication
management go hand-in-hand, and this research project provided additional support for this
assertion. Communication and management systems that are technology-based, including the use
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of electronic health records (EHRs) could provide a foundation for communications between
varied practitioners in the rural mental health facility and help to reduce the level of
polypharmacy.
The aim of this DNP project was to create a quality improvement program for reducing
polypharmacy in elderly patients in a rural outpatient psychiatric clinic. The policy changes
produced in this project were designed to ensure reductions in polypharmacy and support
measures for improved quality. These perspectives were seen through narrative data on a
departmental level that supports the continued development of this kind of a change protocol.
This information suggests the need for continued study of the impacts of EHRs in the clinical
setting and continued research into the best approaches to reducing adverse events from poor
medication management.
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Appendix A: Policy Final Product
Purpose: Following are the central components of the policy’s purpose:
•

To establish a set of guidelines for the use of electronic health records (EHRs) in the rural
health care facility;

•

To create the parameters by which EHRs will be used to ensure the accuracy of patient
prescribing, thus reducing medication errors;

•

To meet medical records compliance requirements set forth by the Federal and State
Laws;

•

To ensure the confidentiality of every patient.

Scope: This policy applies to all employees and management of the rural mental health facility
across all departments, including any practitioners contracted to work on behalf of the facility.

Responsibility: Physicians, nursing staff, mental health practitioners, clinicians, and medical
records/billing staff at the rural mental health facility.

Policy: The rural mental health facility will ensure the maintenance and protection of health
records in alignment with legal requirements. After implementation, each patient will participate
in an in-take interview that will include a review and documentation in EHR of all medications
and OTC products utilized by the patient, in addition to health status updates. EHRs will be used
to ensure the adequate sharing of technology-based patient information to support appropriate
care; the use of the EHR by practitioners with licensure to prescribe medications, including
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access to and review of patient EHR prior to prescribing any medication; the entering of
prescribed medications, and the review of any flags that occur prior to distributing medications
to a patient; the documentation of any subsequent medication conflicts; practitioner-topractitioner communications; and changes made to prescribed medications or medication
management plans in the EHR.

Confidentiality: All personnel who have access to patient protected health records must sign a
Confidentiality Agreement that assures the privacy of password and patient information, and the
protection of access points. Access to EHRs will be protected in accordance with HIPAA
regulations in regards to the retrieval, availability, accessibility and confidentiality of personal
patient information.

Patient Referral and Tracking: EHRs will also be utilized to support increased communication
during patient referral or transfer to other mental health facilities or practitioners, and this
includes managing EHR operations in real-time to maintain the immediacy and accuracy of
patient information as they move between practitioners.
Reference
Health Insurance Portability and Accountability Act (HIPAA) Privacy & Security Rule, 45 CFR
160-164.524
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Appendix B: Practice Guidelines
The practice guidelines for the rural health care facility are based on two specific aims: 1. To
create a systems-oriented approach to maintaining the safety of all patients, and 2. To create a
safe environment within which all patients can work towards their personal goals by recognizing
the errors, their causes, and a strategic approach for change. Following are the guiding points for
practice:
1.

Adopt the use of EHRs as a part of a systems approach to reducing medication errors in
the rural mental health facility;

2.

Utilize EHRs as a means of systematically documenting patients at each stage of their
treatment, including their intake, assessments, medication management, outtake, and
referral or transfer.

3.

Maintain the confidentiality of each practitioner accessing patient care.

4.

Utilize EHRs to ensure that reporting mechanisms are updated in real-time and can
support communication across departments.

5.

Provide physicians, clinics, nursing professionals, and others involved in medication
administration with the skill they need to effectively assess patient condition, identify red
flags, and use technology as a basis for communication with other practitioners providing
care.

6.

Support the use of EHRs in every department in the organization.

7.

Create training for practitioner groups in order to improve the quality of medication
management.
Guidelines

Approach
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Adopting EHRs to Reduce Mediation

Nursing staff will document EHRs at intake and the

Management

information will be used by physicians, nurse
practitioners and other professionals with
prescribing licensure to make medication
management decisions.

Systematic Documentation at Each Patient

Any mental health professionals working directly

Stage

with patients will access and update EHRs
whenever treatment is provided. Documentation will
include: updating medication information, relating
OTC medication use, relating significant alterations
in health that can impact decision-making.

Confidentiality

The Privacy Rule provides that an individual has a
right to adequate notice of how a covered entity may
use and disclose protected health information about
the individual, as well as his or her rights and the
covered entity’s obligations with respect to that
information (HIPAA, 2003). Because a variety of
access points exist for the EHR technology, the
Privacy Rule will be applied to protection of patient
information at remote locations. Passwords will be
identified through a generated system and clinicians
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will have to utilize these to log into specific
information.
Real-Time Communication

All health professionals will document their
interactions with patients and any alteration of
patient information while working directly with the
patient. The person-to-person sharing of information
in real time is based on the importance of this
information that is needed for change.

Prescribing Professional Process

The following process will be followed:
Review of EHR information;
Input of new patient information;
Update of medication management plan;
Identification of new prescription;
Input of new prescription;
Evaluation of any red flags;
Communication with other prescribing
professionals, when needed;
Subsequent update of any new or changing
prescribing plan.

Training

Two mandatory training programs will be conducted
prior to use of the new system. Key components of
the training program will include the
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rationale/purpose of the approach, the systematic
approach to be utilized, methods for evaluating the
outcomes, assessments and communications utilized
between practitioners, and the importance of realtime action and communication.
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Appendix C: Implementation Plan
The implementation plan was developed with the goal of assessing the levels of polypharmacy and the nature of adverse
events prior to the integration at each level of the organization.

Organizational

EHR Access Points

Prescribing Systems

Levels of Polypharmacy

Reporting Systems

Identify key access

Apply overarching

Identify the nature of the

Integrate technology-based

points and determine

organizational

problem for the

operations to improve

which departments will directives to determine organization as a whole

reporting systems, including

be utilizing EHR

the application of EHR through reporting systems Medicare, Medicaid and

systems.

systems for

and the identification of

health insurance reporting

practitioners

polypharmacy in patient

mechanisms.

responsible for patient populations.
prescribing.
Departmental

Define those

Identify those involved Assess incidences of

responsible for access in prescribing systems polypharmacy and issues

Provide training and
systematic support for the
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point protection.

at each organizational related to poor

continued application of

tier.

technology.

performance levels and
continually increasing
polypharmacy rates.

74
Appendix D: Evaluation Plan
The evaluation plan was utilized to determine variations in outcomes through the
process of implementing policies and practice guidelines. Following is the organizational
rubric that could be used to relate the progress of the program over time.
Planning

Initial Stage Strategic

Policy

Implementation Assessment
Communications

Polypharmacy

Adverse Events

Successful
Outcomes
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Appendix E: Potential Organizational Implementation Outcomes

Organizational

EHR Access Points

Prescribing Systems

Levels of Polypharmacy

Alcohol and Drug Use

Start with prescribing

The narrative reflections of Only the billing

Child and Adolescent

mechanisms for

members of the

Services

departments with direct

multidisciplinary team and utilized technology-based

Geriatric Psychiatry

involvement in geriatric

assessments of their

Women’s Mental Health

care, including Alcohol

charting system suggest that operations, based on the

Clinical Services

and Drug Use, Depression polypharmacy occurs in

need for mechanized

and Anxiety Specialists,

almost 25 percent of cases

reporting systems for

Geriatric Psychiatry,

seen in the mental health

Medicaid and Medicare.

Women’s Mental Health,

facility. Adverse events

and Clinical Services

related to polypharmacy

departments.

occur in only about 5
percent of cases, but
members of the team
maintained that

Reporting Systems

department currently

reporting for their
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polypharmacy significantly
reduces the effectiveness of
care.
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Appendix F: Potential Departmental Implementation Outcomes
EHR Access Points

Prescribing Systems

Levels of Polypharmacy

Reporting Systems

Departmental: Ex. Physicians

Physicians, psychiatrists, Higher overall rates of

After implementation, the

Geriatric

Psychiatrists

and nurse practitioners all polypharmacy were noted in this

Geriatric Psychology

Psychology

Nurse Practitioners

have prescribing

department will relate

Nurses

responsibilities that can be patients were noted as having

concerns about the

Psychologists

impacted by the

multiple prescribers for the same

reporting mechanisms and

Social Workers

organizational change

medication. Nurses at in-take will other issues that might

initiative. Nurses,

be asked to interview patients

arise, e.g. the need for a

psychologists and social

regarding prescribed drug use,

shift in approaches to

workers may provide

medication management, OTC

training or maintaining a

information within the

drug use, and recreational drug use skilled population of

EHR system that can

at the time of in-take. Nurses and professionals in the rural

impact decision-making

nurse practitioners will be

regarding prescribing,

responsible for identifying or

population. About 30 percent of

including the presence of noting any prescription

mental health facility.
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prescriptions from other

discrepancies or significant

practitioners, the

potential interactions, though it

identification of OTC

may be difficult to follow through

drug use, or the presence with this kind of approach without
of comorbid substance use the use of technology and without
disorders.

specific accurate information
about existing prescriptions,
medication management strategies,
and communications between
prescribers in and out of the
facility.
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Appendix G: Evaluation Plan Results
The evaluation plan was utilized to determine variations in the outcomes through sharing
with others in the field the policies and practice guidelines from Appendices A-B. This
information is provided in narrative form with some quotes from multidisciplinary team
members to support specific assertions.
Planning

Strategic

Policy Assessment Successful

Implementation
Communications Adequate

Outcomes

The

Policy changes

Communications

communications

multidisciplinary

resulted in a

were improved

about planning

team were

comparison of old

across departments

were accomplished successful in

and new approaches through the

through the

creating a clear

and this improved

multidisciplinary

multidisciplinary

view of the

communication

team approach, as

team. (“Planning

implementation

between

noted through

went very well and process that would practitioners.

reflections of the

people were very

be applied. (“The

(“Many of us didn’t team.

cooperative.”)

creation of clear

realize how little we

directives” was

communicated until

noted.).

we [viewed the]
policy.”)

Polypharmacy

Planning

All members of the The needed changes Protocols for the

incorporated direct multidisciplinary
assessments of

in policy were

assessment of

team were on board clearly aligned with polypharmacy were
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departmental and

with the process of the directive to

identified and,

organizational

strategic

reduce

when implemented,

views of the

implementation to

polypharmacy on

could be compared

problem.

reduce

departmental and

to past rates to

polypharmacy. The organizational

determine areas of

goals were

continued

levels.

developed and

improvement.

utilized as a part of
the directive for
strategic change.
Adverse Events The planning

Clearer

Policies identified

The attainment of

process reflected

identification of

by the

zero adverse events

the fact that

adverse events

multidisciplinary

was the goal to be

adverse events

would include an

team also identified achieved once the

were not always

evaluation of past

discrepancies in

plan was

identified as

events as a part of

views of adverse

implemented, as

directly related to the strategic process events.

was clearly

polypharmacy.

in departments

outlined in the

where the strategy

methods for

would be applied.

implementation
and evaluation.

